The Benchmark Clinic: An Interdisciplinary Comprehensive Care Model for People With Parkinson Disease
The purpose of this study is to determine if an interdisciplinary clinic can help people with Parkinson's disease care for themselves, improve their ability to follow recommended treatments, and have fewer problems like falls or visits to the emergency room.
Participants will be randomly assigned to receive either care from the interdisciplinary clinic or standard neurological specialist care.
This study involves questionnaires both before and 3 months after participation in a one time interdisciplinary care clinic or standard care depending on which type of care the participant is randomized to. Participants will be in the study for up to 6 months. The study will end upon completion of questionnaires about 3 months after treatment with the interdisciplinary care clinic or standard care.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
North Carolina
-
Durham、North Carolina、アメリカ、27710
- Duke University
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Patients with Parkinson's Disease over the age of 30,
- Caregiver willing to also participate.
- Must be able to provide consent.
Exclusion Criteria:
-Atypical Parkinsonism
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Interdisciplinary Care
If assigned to the interdisciplinary group, participants will see social work, physical therapy, occupational therapy, speech therapy, and pharmacy in a scheduled rotation for about 45 minutes each.
After these evaluations, the team meets with the participant's doctor for a discussion of treatment.
After this meeting, the participants doctor will meet to discuss a treatment plan and make recommendations.
|
If assigned to the interdisciplinary group, participants will see social work, physical therapy, occupational therapy, speech therapy, and pharmacy in a scheduled rotation for about 45 minutes each.
After these evaluations, the team meets with the participants doctor for a discussion of treatment.
After this meeting, the participants doctor will meet to discuss a treatment plan and make recommendations.
|
介入なし:Standard of Care
If assigned to standard of care, group participants will have a normally scheduled visit with neurologist.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in composite score on self-efficacy scale
時間枠:Baseline, 3 months after interdisciplinary or standard clinic visit
|
Title of scale: Self-efficacy Scale for Chronic Diseases.
This is a validated scale.
Minimum score is 1, Maximum score is 10.
Higher score is a better outcome.
|
Baseline, 3 months after interdisciplinary or standard clinic visit
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in total weekly minutes exercised as measured by patient engagement survey.
時間枠:Baseline, 3 months after interdisciplinary or standard care visit
|
Investigator developed patient engagement survey
|
Baseline, 3 months after interdisciplinary or standard care visit
|
Change in caregiver burden score on Zarit Burden Interview scale
時間枠:Baseline, 3 months after interdisciplinary or standard care visit
|
Title of scale: Zarit Burden Interview.
This is validated scale.
Minimum score is 0. Maximum score is 88.
Higher score is a worse outcome.
|
Baseline, 3 months after interdisciplinary or standard care visit
|
Number of skilled therapy visits as reported by participant
時間枠:Baseline, 3 months after interdisciplinary or standard care visit
|
Number of skilled therapy visits as reported by participant
|
Baseline, 3 months after interdisciplinary or standard care visit
|
Number of hospitalizations as reported by participant and medical record review
時間枠:Baseline, 3-6 months after interdisciplinary or standard care visit
|
Number of hospitalizations as reported by participant and medical record review
|
Baseline, 3-6 months after interdisciplinary or standard care visit
|
Number of ER visits as reported by participant and medical record review
時間枠:Baseline, 3-6 months after interdisciplinary or standard care visit
|
Number of ER visits as reported by participant and medical record review
|
Baseline, 3-6 months after interdisciplinary or standard care visit
|
Number of falls as reported by participant
時間枠:Baseline, 3 months after interdisciplinary or standard care visit
|
Number of falls as reported by participant
|
Baseline, 3 months after interdisciplinary or standard care visit
|
Number of contraindicated medication combinations as determined by medical record review
時間枠:Baseline, 3-6 months after interdisciplinary or standard care visit
|
Number of contraindicated medication combinations as determined by medical record review
|
Baseline, 3-6 months after interdisciplinary or standard care visit
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Kyle Mitchell, MD、Duke University
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
パーキンソン病の臨床試験
-
Adelphi Values LLCBlueprint Medicines Corporation完了肥満細胞性白血病 (MCL) | 攻撃的な全身性肥満細胞症 (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | くすぶり全身性肥満細胞症 (SSM) | 無痛性全身性肥満細胞症 (ISM) ISM サブグループが完全に募集されましたアメリカ
Interdisciplinary Visitの臨床試験
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge終了しました
-
NanOlogy, LLCUS Biotest, Inc.完了泌尿器科の新生物 | 泌尿生殖器腫瘍 | 膀胱がん | 膀胱がん | 尿路上皮がん | 泌尿器がん | 膀胱腫瘍 | 膀胱がん | 膀胱の悪性腫瘍アメリカ